% Encoding: UTF-8

@Article{amalina2017doxorubicin,
  author   = {Amalina, Nur Dina and Nurhayati, Ika Putri and Meiyanto, Edy},
  title    = {Doxorubicin Induces Lamellipodia Formation and Cell Migration},
  journal  = {Indonesian Journal of Cancer Chemoprevention},
  year     = {2017},
  volume   = {8},
  number   = {2},
  pages    = {61--67},
  abstract = {Breast cancer is the main cause of cancer death among women, especially breast cancer metastasis. Metastasis process begins with the ability of cell cancer invasion. Doxorubicin, a antracycline chemotheraphy, is known to induce TGFβ1, thus promote invasion. The aim of this study is to optimize doxorubicin doses to induce lamellipodia formation in 4T1 and MCF-7/HER2 cells. Lamellipodia formation was observed by morphological changes using microscope inverted. The effect of doxorubicin on cell viability was analyzed using MTT assay. Rac1 expression after doxorubicin exposure was determined by western blotting. Lamellipodia formation was observed by morphological change of the cell at the dose 10, 25, 50 and 100 nM. Doxorubicin at the dose of 10 nM could induced lamellipodia formation without affect cell viability in both 4T1 and MCF-7/HER2 cells.  Doxorubicin induced cell cycle arrest at G2/M phase at all doses. Doxorubicin 10 nM also decrease Rac1 expression compared to control.

Key words: Doxorubicin, lamellipodia, Rac1, migration.},
}

@Article{bradke2008phenylboronic,
  author    = {Bradke, Tiffany M and Hall, Casey and Carper, Stephen W and Plopper, George E},
  title     = {Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability},
  journal   = {Cell adhesion \& migration},
  year      = {2008},
  volume    = {2},
  number    = {3},
  pages     = {153--160},
  abstract  = {We compared the in vitro effect of boric acid (BA) versus phenylboronic acid (PBA) on the migration of prostate and breast cancer cell lines and non-tumorigenic cells from the same tissues. Treatment at 24 hours with BA (≤ 500 µM) did not inhibit chemotaxis on fibronectin in any cell line. However, treatment over the same time course with concentrations of PBA as low as 1 µM significantly inhibited cancer cell migration without effecting non-tumorigenic cell lines. The compounds did not affect cell adhesion or viability at 24 hours but did alter morphology; both decreased cancer cell viability at 8 days. These results suggest that PBA is more potent than BA in targeting the metastatic and proliferative properties of cancer cells.},
  publisher = {Taylor \& Francis},
}

@Article{cao2014curcumin,
  author    = {Cao, Jiatian and Han, Zhihua and Tian, Lei and Chen, Kan and Fan, Yuqi and Ye, Bozhi and Huang, Weijian and Wang, Changqian and Huang, Zhouqing},
  title     = {Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages},
  journal   = {Journal of translational medicine},
  year      = {2014},
  volume    = {12},
  number    = {1},
  pages     = {266},
  publisher = {BioMed Central},
}

@Article{dupre2007mouse,
  author    = {DuPr{\'e}, Sally A and Redelman, Doug and Hunter Jr, Kenneth W},
  title     = {The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci},
  journal   = {International journal of experimental pathology},
  year      = {2007},
  volume    = {88},
  number    = {5},
  pages     = {351--360},
  publisher = {Wiley Online Library},
}

@Article{heppner2000nontransgenic,
  author    = {Heppner, Gloria H and Miller, Fred R and Shekhar, PV Malathy},
  title     = {Nontransgenic models of breast cancer},
  journal   = {Breast Cancer Research},
  year      = {2000},
  volume    = {2},
  number    = {5},
  pages     = {331},
  publisher = {BioMed Central},
}

@Article{larasati2018curcumin,
  author    = {Larasati, Yonika Arum and Yoneda-Kato, Noriko and Nakamae, Ikuko and Yokoyama, Takashi and Meiyanto, Edy and Kato, Jun-ya},
  title     = {Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth},
  journal   = {Scientific reports},
  year      = {2018},
  volume    = {8},
  number    = {1},
  pages     = {2039},
  publisher = {Nature Publishing Group},
}

@Article{mcauley2011phenylboronic,
  author    = {McAuley, Erin M and Bradke, Tiffany A and Plopper, George E},
  title     = {Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration},
  journal   = {Cell adhesion \& migration},
  year      = {2011},
  volume    = {5},
  number    = {5},
  pages     = {382--386},
  publisher = {Taylor \& Francis},
}

@Article{meiyanto2014curcumin,
  author  = {Meiyanto, Edy and Putri, DD and Susidarti, Ratna Asmah and Murwanti, Retno and Sardjiman, Fitriasari A and Husnaa, Ulfatul and Purnomo, Hari and Kawaichi, Masashi},
  title   = {Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation},
  journal = {Asian Pac J Cancer Prev},
  year    = {2014},
  volume  = {15},
  number  = {1},
  pages   = {179--184},
}

@Article{moirangthem2016simultaneous,
  author    = {Moirangthem, Anuradha and Bondhopadhyay, Banashree and Mukherjee, Mala and Bandyopadhyay, Arghya and Mukherjee, Narendranath and Konar, Karabi and Bhattacharya, Shubham and Basu, Anupam},
  title     = {Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes},
  journal   = {Scientific reports},
  year      = {2016},
  volume    = {6},
  pages     = {21903},
  publisher = {Nature Publishing Group},
}

@Article{putri2016combination,
  author    = {Putri, Herwandhani and Jenie, Riris Istighfari and Handayani, Sri and Kastian, Ria Fajarwati and Meiyanto, Edy},
  title     = {Combination of potassium pentagamavunon-0 and doxorubicin induces apoptosis and cell cycle arrest and inhibits metastasis in breast cancer cells},
  journal   = {Asian Pacific Journal of Cancer Prevention},
  year      = {2016},
  volume    = {17},
  number    = {5},
  pages     = {2683--2688},
  publisher = {West Asia Organization for Cancer Prevention (WAOCP)},
}

@Article{song2013prognostic,
  author    = {Song, Jian and Su, Hong and Zhou, Yang-Yang and Guo, Liang-Liang},
  title     = {Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis},
  journal   = {Asian Pacific Journal of Cancer Prevention},
  year      = {2013},
  volume    = {14},
  number    = {3},
  pages     = {1615--1621},
  publisher = {Asian Pacific Organization for Cancer Prevetion},
}

@Article{utomo2017synthesis,
  author  = {Utomo, Rohmad Yudi and Putri, Herwandhani and Pudjono, Pudjono and Susidarti, Ratna Asmah and Jenie, Riris Istighfari and Meiyanto, Edy},
  title   = {SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2, 5-BIS (4-BORONIC ACID) BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS},
  journal = {INDONESIAN JOURNAL OF PHARMACY},
  year    = {2017},
  volume  = {28},
  number  = {2},
  pages   = {74},
}

@Article{vandooren2013biochemistry,
  author    = {Vandooren, Jennifer and Van den Steen, Philippe E and Opdenakker, Ghislain},
  title     = {Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade},
  journal   = {Critical reviews in biochemistry and molecular biology},
  year      = {2013},
  volume    = {48},
  number    = {3},
  pages     = {222--272},
  publisher = {Taylor \& Francis},
}

@Article{yoshino1989improvement,
  author  = {Yoshino, K and Suzuki, A and Mori, Y and Kakihana, H and Honda, C and Mishima, Y and Kobayashi, T and Kanda, K},
  title   = {Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides.},
  journal = {Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft...[et al]},
  year    = {1989},
  volume  = {165},
  number  = {2-3},
  pages   = {127--129},
}

@Article{wallace2003doxorubicin,
  author    = {Wallace, Kendall B},
  title     = {Doxorubicin-induced Cardiac Mitochondrionopathy},
  journal   = {Pharmacology \& Toxicology},
  year      = {2003},
  volume    = {93},
  number    = {3},
  pages     = {105--115},
  publisher = {Pharmacology \& Toxicology},
}

@Comment{jabref-meta: databaseType:bibtex;}